23 October 2026 in Medicine
ABO blood group antigens have been associated with various cardiovascular and inflammatory diseases; however, their relationship with peripheral nervous system disorders remains unclear. The primary aim of this study was to investigate the association between ABO and Rh blood groups and diabetic polyneuropathy in a large hospital-based population; the secondary aim was to evaluate the potential association of these blood groups with nondiabetic polyneuropathy. In this retrospective study, records of individuals with available ABO and Rh blood group data between January 2014 and December 2025 were reviewed. Participants were categorized into 3 groups: controls without peripheral neuropathy, patients with polyneuropathy without diabetes mellitus (nondiabetic polyneuropathy), and patients with diabetic polyneuropathy. A total of 21,427 individuals were included after applying the eligibility criteria and data cleaning. Blood group distributions were compared among the groups, and multinomial logistic regression analysis was performed to evaluate associations with disease status after adjustment for age, sex, and Rh factor. The study included 18,150 controls, 1697 patients with nondiabetic polyneuropathy, and 1580 patients with diabetic polyneuropathy. No significant differences were observed among the 3 groups in terms of ABO blood group distribution or Rh factor. After adjustment for age, sex, and Rh factor, no significant association was found between ABO blood groups and nondiabetic polyneuropathy. In contrast, blood group A was associated with higher odds of diabetic polyneuropathy compared with blood group O (adjusted OR 1.171, 95% CI 1.031–1.330; P = .015). The Rh factor was not significantly associated with either condition after adjustment for the available covariates. Blood group A was associated with diabetic polyneuropathy, whereas no significant association was found between ABO blood groups and nondiabetic polyneuropathy. Given the etiological heterogeneity of nondiabetic polyneuropathy and the retrospective nature of the study, these findings should be interpreted with caution and further evaluated in prospective studies with appropriate control groups and etiologically more homogeneous patient populations.
1 September 2026 in Sanatorium Medical Journal
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare, inherited cerebral microvascular disease primarily caused by mutations in the NOTCH3 gene, leading to a spectrum of neurological symptoms including recurrent strokes, cognitive decline, migraine with aura, and mood disturbances. This report presents the clinical course of a 52-year-old male patient who presented with neurological symptoms beginning at age 50 and was subsequently diagnosed with CADASIL following genetic analysis. Notably, the patient also exhibited early-onset epilepsy, a less common finding in CADASIL which typically manifests later. A further unique aspect was concurrent thrombophilia, complicating treatment significantly. Initial anticoagulant therapy resulted in a new ischemic event, necessitating a switch to dual antiplatelet therapy due to CADASIL's microbleed risk. This case underscores CADASIL's diagnostic complexities, especially with comorbid genetic factors and atypical presentations like early epilepsy, stressing the need for multidisciplinary care and individualized risk-benefit assessments in management.
23 March 2026 in Sakarya Medical Journal
Objective: This report aims to present two atypical cases of autoimmune limbic encephalitis with distinct clinical manifestations and to emphasize the diagnostic challenges when neuroimaging findings are normal or non-specific.Methods: Comprehensive clinical, neurological, and psychiatric evaluations were performed. Diagnostic work-up included brain magnetic resonance imaging (MRI), electroencephalography (EEG), cerebrospinal fluid (CSF) analysis, and autoimmune antibody testing.Results: The first case was a 34-year-old male presenting with isolated executive dysfunction without psychosis, seizures, or movement disorders. MRI showed minimal nonspecific hyperintensities and EEG was normal. CSF analysis revealed mildly elevated protein and strongly positive anti-NMDAR antibodies. Significant cognitive improvement was observed after intravenous methylprednisolone followed by azathioprine. The second case was a 69-year-old male presenting with acute consciousness impairment due to non-convulsive status epilepticus. EEG demonstrated continuous 2–3 Hz spike-wave activity predominantly in the left hemisphere. CSF protein levels were elevated and GAD65 antibodies were positive. Clinical improvement was achieved after treatment with high-dose corticosteroids and intravenous immunoglobulin.Conclusions: Autoimmune encephalitis may present with heterogeneous and atypical clinical features, including isolated cognitive dysfunction or non-convulsive status epilepticus. Normal or nonspecific MRI findings do not exclude the diagnosis. Early recognition and timely immunotherapy are crucial to prevent irreversible neurological damage.
16 June 2026 in International Journal of Evidence Based Coaching and Mentoring
This study examined whether a single coaching session produces psychological and measurable neurobiochemical effects. Fifteen participants with previous coaching expertise engaged in a one-group pretest and posttest design. High-performance liquid chromatography examined plasma dopamine–norepinephrine, and the Positive and Negative Affect Schedule rated mood. Positive affect exhibited a considerable enhancement ( p = .002), while negative affect demonstrated a notable reduction ( p = .006). Hormonal alterations were not statistically significant; nevertheless, a relative rise in dopamine and a reduction in norepinephrine were noted. These findings indicate that a single session has substantial immediate psychological advantages, and corresponding neurobiological patterns point to possible directions for further study.